Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 6;74(5):712-714.
doi: 10.1016/j.jacc.2019.05.051.

Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol Guidelines

Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol Guidelines

Salim S Virani et al. J Am Coll Cardiol. .

Similar articles

See all similar articles

Cited by 2 articles

Publication types

Feedback